Tvardi Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing small molecule therapies targeting STAT3 for fibrosis-driven diseases, has announced its participation in several upcoming investor conferences. These include the JonesTrading C-Suite Fireside Chat Series on Wednesday, February 19, 2026, at 11:00 AM EST (registration link here); the Oppenheimer 36th Annual Healthcare Life Sciences Conference with a corporate presentation on Wednesday, February 25, 2026, at 10:40 AM EST (virtual format); the TD Cowen 46th Annual Health Care Conference with a corporate presentation on Tuesday, March 3, 2026, at 1:50 PM EST in Boston, MA; and the Barclays 28th Annual Global Healthcare Conference with a fireside chat on Tuesday, March 10, 2026, at 2:00 PM EST in Miami Beach, FL. Webcasts of the JonesTrading fireside chat and Oppenheimer presentation will be accessible on the Tvardi Investors' website, with replays available for approximately 90 days following the conferences.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tvardi Therapeutics Inc. published the original content used to generate this news brief on February 12, 2026, and is solely responsible for the information contained therein.